Customer Logins

Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.

Customer Logins

Gustav Ando

Vice President, Industry Services & Life Sciences, IHS Markit

Gustav Ando has overall responsibility for life sciences and comparative industry outlooks

Mr. Ando oversees the development of IHS Markit's global healthcare outlook analysis that focuses on market access, cost of healthcare and new treatment advances as well as coordinating its ongoing thinking on COVID-19. He heads the research and data teams that produce daily analysis, risk assessment and critical data for the pharmaceutical industry, as well as the consulting team that focuses on disease prevention, workforce and demand healthcare microsimulation models. With more than 15 years of experience in the industry, he is a regular speaker at conferences and is frequently cited by major media publications and national radio and television programs. He is the author and podium presenter of research at numerous academic conferences such as ISPOR. Mr Ando also oversees our global comparative industry group which provide critical long-term forecast perspectives across all industries around the world, as well as our specialised global constructrion group. Mr. Ando holds a postgraduate degree from the University of Uppsala, Sweden, and an undergraduate degree from the University of Durham in the United Kingdom.

  • Life Sciences
  • Market Analysis & Forecasts
  • Exploration & Production (E&P)
  • Industry Monitoring and Trends

Related Content

Upcoming Events

IHS Markit Webinar 01 October 2020

Life Sciences Outlook

Following the executive order on 13 September to l (...)

Learn more
IHS Markit Webinar 23 September 2020

Economic Policy Summit 2020 - Day 1

Join our IHS Markit experts, including Chief Econo (...)

Learn more
IHS Markit Webinar 16 December 2020

Top-10 Economic Predictions for 2021: Overcom (...)

While the COVID-19 virus will be with us throughou (...)

Learn more

View Similar Experts

Timothy Dall
Managing Director - Consulting, Life Sciences, Economics and Country Risk, IHS Markit

April Semilla
Associate Director, Life Sciences

Milena Izmirlieva
Director, Life Sciences Research, IHS Markit

Filter Sort